永顺WINSUN品牌怎么样 申请店铺

创立于2002年，专注于禽流感疫苗领域，专业从事动物生物制品研发/生产/销售/服务于一体的现代企业

广东永顺生物制药股份有限公司成立于2002年，是一家集动物生物制品研发、生产、销售、服务于一体的现代技术企业，于2016年11月挂牌新三板，证券代码：永顺生物（839729）。

公司位于广东省广州市黄埔区，总占地面积40000平方米，通过农业部兽药GMP验收，拥有禽流感灭活疫苗车间、普通灭活疫苗车间及活疫苗车间共十一条生产线，年产能达150亿（羽）头份。主要产品为猪瘟活疫苗、猪繁殖障碍与呼吸综合征活疫苗、猪伪狂犬病活疫苗、禽流感灭活疫苗等，年销售收入约4亿元。公司为农业部  猪瘟活疫苗 、 高致病性猪蓝耳病疫苗 、 高致病性禽流感灭活疫苗(H5N1亚型) 、 猪链球菌2型灭活疫苗 定点生产企业。并已组建广东省动物生物制品科技创新中心、广州市及广东省工程技术研究开发中心。

Founded in 2002, Guangdong Yongshun biopharmaceutical Co., Ltd., a modern enterprise specializing in research and development / production / sales / service of animal biological products, is a modern technology enterprise integrating research and development, production, sales and service of animal biological products. It was listed on the new third board in November 2016 with the securities code of Yongshun Sheng Object (839729). The company is located in Huangpu District, Guangzhou City, Guangdong Province, with a total area of 40000 square meters. It has passed the GMP acceptance of veterinary medicine by the Ministry of agriculture. It has 11 production lines, including avian influenza inactivated vaccine workshop, general inactivated vaccine workshop and live vaccine workshop, with an annual production capacity of 15 billion (feather). The main products are live swine fever vaccine, live swine reproductive disorders and respiratory syndrome vaccine, live Swine Pseudorabies Vaccine, and inactivated avian influenza vaccine, with an annual sales revenue of about 400 million yuan. The company is a designated manufacturer of live swine fever vaccine, highly pathogenic swine blue ear disease vaccine, highly pathogenic avian influenza inactivated vaccine (H5N1 subtype) and Streptococcus suis type 2 inactivated vaccine of the Ministry of agriculture. And has established Guangdong animal biological products science and technology innovation center, Guangzhou City and Guangdong engineering technology research and development center.

本文链接： https://brand.waitui.com/29783c7ef.html 联系电话：02032222566